Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETRUMADENANT for Lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ETRUMADENANT was used for Lymphoma.

Most Reported Side Effects for ETRUMADENANT

Side Effect Reports % Deaths Hosp.
Disease progression 19 27.1% 19 19
Febrile neutropenia 16 22.9% 9 15
Platelet count decreased 15 21.4% 9 14
Pyrexia 14 20.0% 2 14
Hyponatraemia 12 17.1% 9 12
Drug hypersensitivity 11 15.7% 9 11
Vomiting 11 15.7% 10 11
Diarrhoea 10 14.3% 4 10
Nausea 10 14.3% 9 10
Acute kidney injury 7 10.0% 2 7
Fungal infection 7 10.0% 7 7
Hypersensitivity 7 10.0% 7 7
Neutropenia 7 10.0% 3 7
White blood cell count decreased 7 10.0% 1 6
Anastomotic leak 6 8.6% 0 6

Other Indications for ETRUMADENANT

Colorectal cancer (58) Colorectal cancer metastatic (6)

Other Drugs Used for Lymphoma

RITUXIMAB (3,142) CYCLOPHOSPHAMIDE (1,729) VINCRISTINE (1,452) LENALIDOMIDE (1,427) DOXORUBICIN (1,420) ETOPOSIDE (915) IBRUTINIB (896) PREDNISONE (672) METHOTREXATE (647) CYTARABINE (645)

Related Pages

ETRUMADENANT Full Profile All Lymphoma Drugs ETRUMADENANT Demographics ETRUMADENANT Timeline